Header Logo

Connection

Chun Chao to Prostatic Neoplasms

Back to Details
This is a "connection" page, showing publications Chun Chao has written about Prostatic Neoplasms.
Chun Chao
Connection Strength
3.488
Prostatic Neoplasms
  1. DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer. Epigenetics. 2024 Dec; 19(1):2308920.
    View in: PubMed
    Score: 0.763
  2. Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment. Cancer Med. 2020 11; 9(22):8530-8539.
    View in: PubMed
    Score: 0.599
  3. Methylation markers for prostate cancer prognosis: a systematic review. Cancer Causes Control. 2013 Sep; 24(9):1615-41.
    View in: PubMed
    Score: 0.367
  4. Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy. BJU Int. 2013 May; 111(6):954-62.
    View in: PubMed
    Score: 0.355
  5. Statin therapy is not associated with prostate cancer recurrence among patients who underwent radiation therapy. Cancer Lett. 2013 Jul 10; 335(1):214-8.
    View in: PubMed
    Score: 0.354
  6. Red wine consumption and risk of prostate cancer: the California men's health study. Int J Cancer. 2010 Jan 01; 126(1):171-9.
    View in: PubMed
    Score: 0.285
  7. A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility. Cancer Res. 2021 04 01; 81(7):1695-1703.
    View in: PubMed
    Score: 0.152
  8. Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer. Nat Commun. 2017 01 31; 8:14248.
    View in: PubMed
    Score: 0.116
  9. A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. Cancer Discov. 2015 Aug; 5(8):878-91.
    View in: PubMed
    Score: 0.104
  10. Variability in date of prostate cancer diagnosis: a comparison of cancer registry, pathology report, and electronic health data sources. Ann Epidemiol. 2014 Nov; 24(11):855-60.
    View in: PubMed
    Score: 0.099
  11. Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr. 2014 Aug 15; 66(5):495-502.
    View in: PubMed
    Score: 0.098
  12. Racial and ethnic differences in time to treatment for patients with localized prostate cancer. Urology. 2013 Feb; 81(2):283-7.
    View in: PubMed
    Score: 0.088
  13. Changes in serum prostate-specific antigen levels and the identification of prostate cancer in a large managed care population. BJU Int. 2013 Jun; 111(8):1245-52.
    View in: PubMed
    Score: 0.088
  14. Identifying primary and recurrent cancers using a SAS-based natural language processing algorithm. J Am Med Inform Assoc. 2013 Mar-Apr; 20(2):349-55.
    View in: PubMed
    Score: 0.021

© 2025 Kaiser Permanente